Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 101
- 0 vs. Q2 2025
- Portfolio value
- $421.6M
- +$39.1M (+10.2%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,507,025 | $30.4M | 7.2% | −113,965−7.0% | Reduced | History |
| NICENICE Ltd. | SPONSORED ADR | 157,400 | $22.8M | 5.4% | +157,400 | New | History |
| TSEMTower Semiconductor Ltd | SHS NEW | 311,802 | $22.5M | 5.3% | +47,080+17.8% | Added | History |
| NVMINova Ltd. | COM | 43,896 | $14.0M | 3.3% | −31,940−42.1% | Reduced | History |
| Invesco QQQ Trust Series I46090E103 | ETF | 22,960 | $13.8M | 3.3% | +22,960 | New | – |
| BIIBBiogen Inc. | COM | 82,738 | $11.6M | 2.7% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 352,558 | $10.6M | 2.5% | +252,473+252.3% | Added | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 135,060 | $10.4M | 2.5% | 00.0% | Unchanged | History |
| SNYSanofi | SPONSORED ADR | 219,515 | $10.4M | 2.5% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 161,517 | $8.88M | 2.1% | −165,201−50.6% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 219,910 | $8.34M | 2.0% | −261,064−54.3% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 991,142 | $7.81M | 1.9% | +4240.0% | Added | History |
| LLYEli Lilly & Co | Stock | 10,040 | $7.66M | 1.8% | −1,500−13.0% | Reduced | History |
| JNJJohnson & Johnson | Stock | 40,831 | $7.57M | 1.8% | 00.0% | Unchanged | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 75,743 | $7.25M | 1.7% | −62,258−45.1% | Reduced | History |
| FBRXForte Biosciences, Inc. | COM NEW | 474,309 | $7.11M | 1.7% | −20,800−4.2% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 387,716 | $5.97M | 1.4% | −1,183,848−75.3% | Reduced | History |
| TRVITrevi Therapeutics, Inc. | COM | 643,957 | $5.89M | 1.4% | −156,000−19.5% | Reduced | History |
| NVONovo Nordisk A S | ADR | 105,677 | $5.86M | 1.4% | 00.0% | Unchanged | History |
| ABBVAbbVie Inc. | Stock | 25,256 | $5.85M | 1.4% | 00.0% | Unchanged | History |
| CLBTCellebrite DI Ltd. | ORDINARY SHARES | 298,948 | $5.54M | 1.3% | +298,948 | New | History |
| ANNXAnnexon, Inc. | COM | 1,794,387 | $5.47M | 1.3% | +30,000+1.7% | Added | History |
| DYNDyne Therapeutics, Inc. | COM | 426,518 | $5.40M | 1.3% | +205,102+92.6% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 207,764 | $5.37M | 1.3% | −211,776−50.5% | Reduced | History |
| Solaredge Technologies, Inc.83417MAE4 | NOTE 2.250% 7/0 | 4,000,000 | $5.33M | 1.3% | +4,000,000 | New | – |
| GSKGSK plc | ADR | 122,000 | $5.27M | 1.2% | 00.0% | Unchanged | History |
| SEDGSolaredge Technologies, Inc. | COM | 140,966 | $5.22M | 1.2% | +13,000+10.2% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 431,693 | $5.18M | 1.2% | +37,000+9.4% | Added | History |
| IMTXImmatics N.V. | SHS | 583,105 | $4.97M | 1.2% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 173,931 | $4.87M | 1.2% | +78,000+81.3% | Added | History |
| SVRASavara Inc | COM | 1,350,333 | $4.82M | 1.1% | +40,100+3.1% | Added | History |
| NVSNovartis AG | ADR | 37,000 | $4.74M | 1.1% | 00.0% | Unchanged | History |
| RAPPRapport Therapeutics, Inc. | COM | 157,533 | $4.68M | 1.1% | +157,533 | New | History |
| VRNSVaronis Systems Inc | COM | 73,900 | $4.25M | 1.0% | +73,900 | New | History |
| IMVTImmunovant, Inc. | COM | 256,743 | $4.14M | 1.0% | 00.0% | Unchanged | History |
| MRKMerck & Co., Inc. | Stock | 48,600 | $4.08M | 1.0% | 00.0% | Unchanged | History |
| MAZEMaze Therapeutics, Inc. | COM | 154,343 | $4.00M | 0.9% | −202,110−56.7% | Reduced | History |
| ENGNenGene Therapeutics Inc. | COM | 504,409 | $3.45M | 0.8% | 00.0% | Unchanged | History |
| ESLTElbit Systems Ltd | Stock | 6,740 | $3.44M | 0.8% | +740+12.3% | Added | History |
| RZLTRezolute, Inc. | COM NEW | 363,947 | $3.42M | 0.8% | −387,500−51.6% | Reduced | History |
| ELVNEnliven Therapeutics, Inc. | COM | 166,765 | $3.41M | 0.8% | +38,250+29.8% | Added | History |
| MDWDMediWound Ltd. | SHS NEW | 185,270 | $3.34M | 0.8% | +185,270 | New | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,280,233 | $3.32M | 0.8% | −679,377−34.7% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 148,900 | $3.18M | 0.8% | −26,000−14.9% | Reduced | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 57,901 | $3.07M | 0.7% | −51,856−47.2% | Reduced | History |
| CAMTCamtek Ltd | ORD | 29,048 | $3.05M | 0.7% | −2,928−9.2% | Reduced | History |
| AMZNAmazon Com Inc | Stock | 13,760 | $3.02M | 0.7% | −18,681−57.6% | Reduced | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 407,709 | $3.00M | 0.7% | +224,615+122.7% | Added | History |
| PHVSPharvaris N.V. | COM | 119,406 | $2.98M | 0.7% | −190,525−61.5% | Reduced | History |
| METAMeta Platforms, Inc. | Stock | 3,924 | $2.88M | 0.7% | −4,602−54.0% | Reduced | History |
| SLNOSoleno Therapeutics Inc | COM | 41,606 | $2.81M | 0.7% | +41,606 | New | History |
| RVMDRevolution Medicines, Inc. | COM | 60,000 | $2.80M | 0.7% | +60,000 | New | History |
| ORAOrmat Technologies, Inc. | COM | 29,000 | $2.79M | 0.7% | −49,000−62.8% | Reduced | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 100,000 | $2.72M | 0.6% | +100,000 | New | History |
| AMGNAmgen Inc | Stock | 9,500 | $2.68M | 0.6% | 00.0% | Unchanged | History |
| AMDAdvanced Micro Devices Inc | Stock | 15,470 | $2.50M | 0.6% | +7,220+87.5% | Added | History |
| ACOGAlpha Cognition Inc. | COM NEW | 338,752 | $2.21M | 0.5% | −37,897−10.1% | Reduced | History |
| PFEPfizer Inc | Stock | 86,000 | $2.19M | 0.5% | 00.0% | Unchanged | History |
| HELPHelus Pharma Inc. | COM NEW | 370,376 | $2.18M | 0.5% | −27,933−7.0% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 245,522 | $2.17M | 0.5% | +10,000+4.2% | Added | History |
| AVGOBroadcom Inc. | Stock | 6,555 | $2.16M | 0.5% | +6,555 | New | History |
| CEVACeva Inc | COM | 81,085 | $2.14M | 0.5% | +32,165+65.8% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 40,746 | $2.12M | 0.5% | −46,362−53.2% | Reduced | History |
| JANXJanux Therapeutics, Inc. | COM | 85,840 | $2.10M | 0.5% | 00.0% | Unchanged | History |
| SKYESkye Bioscience, Inc. | COM NEW | 478,928 | $1.88M | 0.4% | −59,506−11.1% | Reduced | History |
| ATXSAstria Therapeutics, Inc. | COM | 251,225 | $1.83M | 0.4% | −6,177−2.4% | Reduced | History |
| TECXTectonic Therapeutic, Inc. | COM | 115,908 | $1.82M | 0.4% | +115,908 | New | History |
| PCVXVaxcyte, Inc. | COM | 50,000 | $1.80M | 0.4% | +50,000 | New | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 510,343 | $1.75M | 0.4% | +200,000+64.4% | Added | History |
| IMNMImmunome Inc. | COM | 147,200 | $1.72M | 0.4% | +147,200 | New | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 820,000 | $1.64M | 0.4% | +820,000 | New | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 629,470 | $1.50M | 0.4% | +614,799+4,190.6% | Added | History |
| QUREuniQure N.V. | SHS | 24,900 | $1.45M | 0.3% | +24,900 | New | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 63,660 | $1.44M | 0.3% | −50,686−44.3% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 98,526 | $1.41M | 0.3% | −45,167−31.4% | Reduced | History |
| IBITiShares Bitcoin Trust ETF | ETF | 21,455 | $1.39M | 0.3% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 440,114 | $1.37M | 0.3% | −115,700−20.8% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 91,155 | $1.37M | 0.3% | −54,217−37.3% | Reduced | History |
| BCAXBicara Therapeutics Inc. | COM | 85,747 | $1.35M | 0.3% | +20,068+30.6% | Added | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 408,146 | $1.33M | 0.3% | −11,854−2.8% | Reduced | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 175,371 | $1.24M | 0.3% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $1.23M | 0.3% | 00.0% | Unchanged | History |
| SABSSAB Biotherapeutics, Inc. | COM NEW | 566,395 | $1.14M | 0.3% | +566,395 | New | History |
| ENPHEnphase Energy, Inc. | Stock | 26,700 | $944.9K | 0.2% | +26,700 | New | History |
| VYGRVoyager Therapeutics, Inc. | COM | 199,761 | $932.9K | 0.2% | +199,761 | New | History |
| CLYMClimb Bio, Inc. | COM | 434,837 | $874.0K | 0.2% | +225,000+107.2% | Added | History |
| LRMRLarimar Therapeutics, Inc. | COM | 260,385 | $841.0K | 0.2% | +63,750+32.4% | Added | History |
| PEPGPepGen Inc. | COM | 171,467 | $792.2K | 0.2% | +15,000+9.6% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 17,500 | $789.3K | 0.2% | 00.0% | Unchanged | History |
| VSTMVerastem, Inc. | COM NEW | 78,307 | $691.5K | 0.2% | −85,000−52.0% | Reduced | History |
| ROIVRoivant Sciences Ltd. | SHS | 42,571 | $644.1K | 0.2% | +42,571 | New | History |
| ETNB89bio, Inc. | COM | 39,675 | $583.2K | 0.1% | −166,000−80.7% | Reduced | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 71,010 | $509.1K | 0.1% | +71,010 | New | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 179,425 | $471.9K | 0.1% | −5,087−2.8% | ReducedConverted for a 1-for-4 split | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 12,496 | $431.0K | 0.1% | −190,500−93.8% | Reduced | History |
| APREAprea Therapeutics, Inc. | COM NEW | 270,000 | $398.3K | 0.1% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 50,000 | $366.0K | 0.1% | +50,000 | New | History |
| OKUROnKure Therapeutics, Inc. | COM CL A | 60,454 | $166.2K | <0.1% | 00.0% | Unchanged | History |
| DSGNDesign Therapeutics, Inc. | COM | 21,918 | $165.0K | <0.1% | +21,918 | New | History |
| PMNProMIS Neurosciences Inc. | COM | 295,187 | $125.5K | <0.1% | −1,604,110−84.5% | Reduced | History |
Options (13)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| MRUSMerus N.V. | COM | – | $14.1M |
| CDTXCidara Therapeutics, Inc. | COM NEW | – | $9.58M |
| BBIOBridgeBio Pharma, Inc. | COM | – | $6.75M |
| QUREuniQure N.V. | SHS | $4.38M | – |
| iShares Tr464287432 | 20 YR TR BD ETF | – | $4.20M |
| SRPTSarepta Therapeutics, Inc. | COM | – | $2.89M |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | – | $2.65M |
| TVTXTravere Therapeutics, Inc. | COM | – | $2.43M |
| ROIVRoivant Sciences Ltd. | SHS | – | $2.29M |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | – | $1.40M |
| TRVITrevi Therapeutics, Inc. | COM | – | $1.18M |
| ELDNEledon Pharmaceuticals, Inc. | COM | $518.0K | – |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | – | $71.7K |
Sold out since Q2 2025 (23)
Positions held at the end of Q2 2025 that are gone from this filing.
| Security | Class | Shares in Q2 2025 | Value in Q2 2025 | % of portfolio in Q2 2025 | History |
|---|---|---|---|---|---|
| NVDANVIDIA Corp | Stock | 54,515 | $8.61M | 2.3% | History |
| MSFTMicrosoft Corp | Stock | 11,792 | $5.87M | 1.5% | History |
| Ormat Technologies, Inc.686688AC6 | DEBT 2.500% 7/1 | 5,037,000 | $5.61M | 1.5% | – |
| TVTXTravere Therapeutics, Inc. | COM | 335,333 | $4.96M | 1.3% | History |
| Avidity Biosciences, Inc.05370A108 | COM | 126,000 | $3.58M | 0.9% | – |
| AMATApplied Materials Inc | Stock | 18,000 | $3.30M | 0.9% | History |
| UBERUber Technologies, Inc | Stock | 30,000 | $2.80M | 0.7% | History |
| SRPTSarepta Therapeutics, Inc. | COM | 159,323 | $2.72M | 0.7% | History |
| PANWPalo Alto Networks Inc | Stock | 13,114 | $2.68M | 0.7% | History |
| WIXWix.com Ltd. | SHS | 16,931 | $2.68M | 0.7% | History |
| SRRKScholar Rock Holding Corp | COM | 57,497 | $2.04M | 0.5% | History |
| CRMSalesforce, Inc. | Stock | 6,800 | $1.85M | 0.5% | History |
| Cyberark Software LtdM2682V108 | SHS | 4,000 | $1.63M | 0.4% | – |
| MRVLMarvell Technology, Inc. | COM | 18,730 | $1.45M | 0.4% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 128,780 | $1.21M | 0.3% | History |
| NNDMNano Dimension Ltd. | SPONSORD ADS NEW | 717,518 | $1.16M | 0.3% | History |
| KRYSKrystal Biotech, Inc. | COM | 7,335 | $1.01M | 0.3% | History |
| VTGNVistagen Therapeutics, Inc. | COM | 447,939 | $895.9K | 0.2% | History |
| SSentinelOne, Inc. | CL A | 27,000 | $493.6K | 0.1% | History |
| CGNTCognyte Software Ltd. | ORD SHS | 45,181 | $417.5K | 0.1% | History |
| KZRKezar Life Sciences, Inc. | COM | 58,539 | $268.1K | 0.1% | History |
| SLDBSolid Biosciences Inc. | COM NEW | 50,190 | $244.4K | 0.1% | History |
| ELEVElevation Acquisition Group Inc. | COM | 328,562 | $120.6K | <0.1% | History |